Details

Autor(en) / Beteiligte

• Yamashita, Shinji
• Takeshima, Hideo
• Hata, Nobuhiro
• Uchida, Hiroyuki
• Shinojima, Naoki
• Yokogami, Kiyotaka
• Nakano, Yoshiteru
• Sakata, Kiyohiko
• Fudaba, Hirotaka
• Enomoto, Toshiyuki
• Nakahara, Yukiko
• Ujifuku, Kenta
• Sugawara, Kenichi
• Iwaki, Tooru
• Sangatsuda, Yuhei
• Yoshimoto, Koji
• Hanaya, Ryousuke
• Mukasa, Akitake
• Suzuki, Kohei
• Yamamoto, Junkoh
• Negoto, Tetsuya
• Nakamura, Hideo
• Momii, Yasutomo
• Fujiki, Minoru
• Abe, Hiroshi
• Masuoka, Jun
• Abe, Tatsuya
• Matsuo, Takayuki
• Ishiuchi, Shogo

Titel

Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group

Ist Teil von

• Journal of neuro-oncology, 2023-04, Vol.162 (2), p.425-433

Ort / Verlag

New York: Springer US

Erscheinungsjahr

2023

Link zum Volltext

Quelle

SpringerLink (Online service)

Beschreibungen/Notizen

• Purpose Pineal parenchymal tumors of intermediate differentiation (PPTIDs), which were recognized in the 2007 World Health Organization (WHO) classification, are rare, accounting for less than 1% of all central nervous system tumors. This rarity and novelty complicate the diagnosis and treatments of PPTID. We therefore aimed to evaluate the clinicopathological significance of this tumor. Methods At 11 institutions participating in the Kyushu Neuro-Oncology Study Group, data for patients diagnosed with PPTID were collected. Central pathology review and KBTBD4 mutation analysis were applied to attain the diagnostically accurate cohort. Results PPTID was officially diagnosed in 28 patients: 11 (39%) with WHO grade 2 and 17 (61%) with WHO grade 3 tumors. Median age was 49 years, and the male:female ratio was 1:2.1. Surgery was attempted in all 28 patients, and gross total resection (GTR) was achieved in 46% (13/28). Adjuvant radiotherapy and chemotherapy were administered to, respectively, 82% (23/28) and 46% (13/28). The 5-year progression-free survival (PFS) and overall survival rates were 64.9% and 70.4% respectively. Female sex (p = 0.018) and GTR (p < 0.01) were found to be independent prognostic factors for PFS and female sex (p = 0.019) was that for OS. Initial and second recurrences were most often leptomeningeal (67% and 100% respectively). 80% (20/25) of patients harbored a KBTBD4 mutation. Conclusions Female sex and GTR were independent prognostic factors in our patients with PPTID. Leptomeningeal recurrence was observed to be particularly characteristic of this tumor. The rate of KBTBD4 mutation observed in our cohort was acceptable and this could prove the accuracy of our PPTID cohort.